Welcure Drugs & Pharmaceuticals Current Share Price | Welcure Drugs & Pharmaceuticals Stock Screener
WELCURE
Pharmaceuticals
Welcure Drugs & Pharmaceuticals Current Stock Price Today
Live Share Price BSE
₹0.21
▼
-0.01 (-4.55%)
As of September 18, 2026, the live Welcure Drugs & Pharmaceuticals share price (BSE: WELCURE) is ₹0.21, down 4.55% from the previous close, with shares trading between ₹0.21 and ₹0.22 in today's trading session, and a 52-week range of ₹0.20–₹7.48.
Browse WELCURE complete financial statements to support your investment research.
Use the Welcure Drugs & Pharmaceuticals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Welcure Drugs & Pharmaceuticals Market Cap
₹27.20 Cr.
WELCURE P/E Ratio (TTM)
-5.50
Welcure Drugs & Pharmaceuticals P/B Ratio
0.28
EPS (TTM)
₹-0.04
Dividend Yield
-
Debt to Equity
1.19
WELCURE 52 Week High
₹7.48
Welcure Drugs & Pharmaceuticals 52 Week Low
₹0.20
Operating Margin
-2.00%
Profit Margin
-1.37%
WELCURE Revenue (TTM)
₹366.00
EBITDA
₹-7.00
Net Income
₹-5.00
Total Assets
₹510.00
Total Equity
₹97.00
Welcure Drugs & Pharmaceuticals Current Share Price Chart
Track the current Welcure Drugs & Pharmaceuticals share price and stock price with an interactive chart. Analyse WELCURE price trends, trading volume, historical performance, and volatility across different timeframes — the complete Welcure Drugs & Pharmaceuticals stock quote in one place.
Welcure Drugs & Pharmaceuticals Company Profile - Fundamental Screener
Screen Welcure Drugs & Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for WELCURE shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE331C01025
Welcure Drugs & Pharmaceuticals Balance Sheet Screener
Screen WELCURE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 510 | 267 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 358 | 182 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 123 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 97 | 103 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Capital | 124 | 112 | 13 | 13 | 12 | 12 | 12 | 12 | 12 | 12 |
| Reserves & Surplus | -27 | -10 | -12 | -12 | -12 | -12 | -12 | -12 | -12 | -12 |
Welcure Drugs & Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Screen Welcure Drugs & Pharmaceuticals income statement and profit fundamentals.
Analyze WELCURE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Welcure Drugs & Pharmaceuticals share price evaluation.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 366 | 27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 372 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -7 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit % | -2.00% | 4.00% | 0.00% | 0.00% | 22.00% | 41.00% | -12.00% | 3.00% | -41.00% | 31.00% | 32.00% | 7.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -5 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -5 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | -0.04 | 0.36 | -0.13 | 0.08 | 0.02 | 0.05 | -0.01 | 0.00 | -0.02 | 0.02 | 0.07 | 0.00 |
Welcure Drugs & Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen WELCURE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -222 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 222 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Welcure Drugs & Pharmaceuticals Shareholding Pattern Screener
See Welcure Drugs & Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings.
Check Welcure Drugs & Pharmaceuticals promoter holding and ownership changes for WELCURE on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 95.63% | 98.99% | 98.74% | 91.83% | 94.41% | 93.69% | 93.14% | 93.55% |
| Other Holding | 4.37% | 1.01% | 1.26% | 8.17% | 5.59% | 6.31% | 6.86% | 6.45% |
| Shareholder Count | 87,977 | 32,366 | 37,298 | 76,954 | 87,288 | 31,530 | 31,045 | 30,218 |
Welcure Drugs & Pharmaceuticals Share Dividend Screener - Share Yield Analysis
Check Welcure Drugs & Pharmaceuticals dividend history with payout and yield data.
View Welcure Drugs & Pharmaceuticals dividend details including ex-dates and amounts for WELCURE stock.
Welcure Drugs & Pharmaceuticals Stock Index Membership
See which indices include Welcure Drugs & Pharmaceuticals stock.
Check WELCURE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Welcure Drugs & Pharmaceuticals Market Events Screener - Corporate Actions
Get Welcure Drugs & Pharmaceuticals corporate actions including splits, bonuses, and buybacks.
Check Welcure Drugs & Pharmaceuticals stock events that may affect WELCURE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | 3.57% |
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | 9.09% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 10.91% |
| 2025-10-16 | 2025-10-16 | Bonus | 1:10 | 23.33% |
| 2025-10-16 | 2025-10-16 | Split | 1:10 | -35.09% |
| 2025-09-27 | 2025-09-27 | Annual General Meeting | NA | -31.25% |
| 2025-08-05 | 2025-08-05 | Quarterly Result Announcement | NA | 2.33% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 6.93% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -10.64% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 4.29% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | 4.48% |
Welcure Drugs & Pharmaceuticals Competitors Screener - Peer Comparison
Screen WELCURE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 441,478 | 36.91 | 61,674 | 12.69% | 11,565 | 34.00 |
| Divis Laboratories | 247,470 | 85.36 | 11,067 | 13.95% | 2,568 | 63.65 |
| Torrent Pharmaceuticals | 188,872 | 86.95 | 13,886 | 20.34% | 2,138 | 52.16 |
| Zydus Life Science | 112,608 | 24.28 | 27,658 | 17.64% | 5,026 | 45.64 |
| Cipla | 110,352 | 33.22 | 29,045 | 2.24% | 3,870 | 35.27 |
| Laurus Labs | 106,298 | 95.94 | 6,868 | 22.01% | 890 | 68.28 |
| Dr Reddys Laboratories | 97,281 | 29.91 | 35,059 | 3.90% | 4,158 | 47.72 |
| Aurobindo Pharma | 96,652 | 25.88 | 34,145 | 5.56% | 3,503 | 57.04 |
| Lupin | 95,790 | 17.09 | 29,039 | 26.75% | 5,356 | 28.17 |
| Mankind Pharma | 94,163 | 44.87 | 14,636 | 14.85% | 1,938 | 37.57 |
Welcure Drugs & Pharmaceuticals Company Announcements - News Screener
Screen WELCURE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-14 | Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Ltd Held On Today I.E. Tuesday 14Th July 2026. | - |
| 2026-06-19 | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | - |
| 2026-06-19 | Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Limited Held On Today I.E. Friday 19Th June 2026 | - |
| 2026-06-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-30 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-29 | Audited Standalone Financial Result For The Quarter And Year Ended 31St March 2026 | - |
| 2026-05-29 | Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Of The Welcure Drugs And Pharmaceuticals Limited Held Today I.E. Friday 29Th May 2026 | - |
| 2026-05-22 | Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results For The Quarter/Year Ended 31St March 2026 Along With Statement Of Assets And Liabilities And Cash Flow Statement For The Year Ended 31St March 2026. | - |
| 2026-04-23 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-03 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-26 | Closure of Trading Window | - |
| 2026-02-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-12 | Unaudited Financial Results For The 3Rd Quarter Ended On 31St December 2025. | - |
| 2026-02-12 | Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Limited Held On Today I.E. Thursday 12Th February 2026 | - |
| 2026-02-07 | Board Meeting Intimation for Intimation Of Meeting Of The Board Of Directors To Be Held On Thursday February 12 2026. | - |
| 2026-01-05 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-24 | Closure of Trading Window | - |
| 2025-12-06 | Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs And Pharmaceuticals Limited Held Today I.E. Saturday December 06 2025 | - |
| 2025-12-05 | Postponement Of The Meeting Of The Rights Issue Committee Of Welcure Drugs And Pharmaceuticals Limited Which Was To Be Held Today I.E. Monday December 05 2025 | - |
| 2025-12-01 | Board Meeting Intimation for Intimation Of Rights Issue Committee Meeting To Be Held On 05Th December 2025 For Deciding Issue Price And Other Terms Of The Rights Issue | - |